Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

MRI Interventions closes $7.5mm PIPE with investment by PTC

Executive Summary

MRI Interventions Inc. (neurosurgical devices) grossed $7.5mm in a private placement of 2.4mm shares at $3.10 (a 4% premium) to 17 investors, led by PTC Therapeutics (adds a board member), which invested $4mm (through the purchase of 1.3mm MRI shares), for a 9.56% stake in the company. In a concurrent supply agreement, PTC will use MRI's neurosurgical portfolio for PTC's current and future gene therapy programs. MRI's offerings include devices with applications in navigation, ablation, deep brain stimulation, biopsy, aspiration, and gene therapy.
Deal Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • MRI, NMR
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies